Emily Ko, MD, MSCR is an assistant professor in the department of Obstetrics and Gynecology, Division of Gynecologic Oncology. As a clinician-researcher, she provides surgical and chemotherapy treatments for women with gynecologic cancers or precancerous conditions. Additionally, Dr. Ko is a researcher with a focus on population science-based studies, clinical trials, and has prior experience in pharmacoepidemiology. Her primary areas of interest include endometrial cancer and cervical cancer. More recently she has incorporated health services research related to the practice and outcomes of gynecologic cancer. Dr. Ko has received institutional funding as well as national grant funding, including from the American Society of Clinical Oncologists Conquer Cancer Foundation and the Gynecologic Oncology Group. In 2016, she was awarded the American Cancer Society Institutional Research Grant to evaluate “Gynecologic Oncology patterns of care, health care utilization, and practice optimization,” in collaboration with Andrew Epstein, PhD, Research Associate Professor of the Perelman School of Medicine. Her extramural activities include working with national leaders in the Society of Gynecologic Oncologists (SGO), previously serving as a member on the Quality and Outcomes committee, and more recently, Chair of the Future of Physicians Payment Reform Taskforce of the SGO Health Policy and Social Economic Committee. At Penn, Dr. Ko is a full member of the Abramson Cancer Center, Clinical Cancer Control division. She also directs the Gynecologic Oncology Population Science Research Group, and mentors multiple trainees through the School of Medicine and MSCE programs. Together, her clinical practice, research efforts, and service commitments have converged, with a focus on evaluations of practice patterns, quality improvement, and strategies to adapt practices in the era of payment reform.